The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Charles River Laboratories ...

The Food and Drug Administation is approving a generic drug for a very rare genetic disorder, but not for autism.

Explore the capabilities of a new AI tool that revolutionizes drug discovery by speeding up molecule formation and reducing costs.

Inside the St. Louis County Medical Examiner's Office, a laboratory is generating what officials describe as a first-of-its-kind.

The Wisconsin Legislature approved saliva tests in late February, another tool for law enforcement to screen for drugged driving during traffic stops, according to Senate Bill 678. The bill would ...

Over the last five years, 14,342 drug samples were found 'Not of Standard Quality' and 1,593 were 'spurious/adulterated' from 492,904 samples tested across India, revealed Health Ministry data ...

New Delhi [India], March 10 (ANI): The manufacture, sale and distribution of drugs are regulated in the country under the provisions of Drugs & Cosmetics Act, 1940 and Rules thereunder through a ...

Cambridge, Massachusetts-- (Newsfile Corp. - March 10, 2026) - R3 Bio announced the release of its 2026 research report outlining early-stage progress in developing integrated, stem cell-derived ...

ViruSure, an Asahi Kasei company and global leader in pathogen safety testing for biopharmaceuticals, today announced the launch of the world's first GMP-validated adventitious viral agent (AVA) ...

WASHINGTON (AP) — The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back statements by President Donald Trump and other administration ...